Pay in 4 interest-free payments of $6.68 Learn more
Ships within 48 hours · Estimated delivery Jul 27 - Aug 1
Disclosure of interest: Mohamed Attia: nothing to disclose E-Posters - NOVEL TARGET/ EXPERIMENTAL FIDINGS TO CLINICAL TRANSLATION 06.00 - NOVEL TARGET/ EXPERIMENTAL FIDINGS TO CLINICAL TRANSLATION - 06.01 - PATHOPHYSIOLOGY OF STROKE / TRANSLATIONAL MEDICINE P2585 - ESOC25-1646 SEX DIFFERENCES IN WEIGHT LOSS AND ASSOCIATION WITH LESION VOLUME FOLLOWING INTRACEREBRAL HAEMORRHAGE IN THE RAT COLLAGENASE MODEL Jonas Vanderhaeghe 1 , Melissa Lajtos 1,2 , Luna Mestrum 1 , Mariska Meersschaut 1 , Robrecht Raedt 1 , Christian Vanhove 2 , Veerle De Herdt 1 1 4BRAIN, Ghent University, Ghent, Belgium, 2 IBiTech-MEDISIP-Infinity, Ghent University, Ghent, Belgium Background and Aims: Intracerebral haemorrhage (ICH) affects over 2 million people worldwide each year, resulting in substantial mortality and morbidity
Body weight-based AOD-9604 dosing protocols Body composition significantly impacts peptide distribution and effectiveness
Its less painful, plus SQ injection sites are more accessible
Diverse pharmacological activities and potential medicinal benefits of geniposide
Semaglutide and Tirzepatide are contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
US$ 21.05
US$ 20.82
US$ 21.77
US$ 27.71
US$ 29.75
US$ 26.01
US$ 22.23
US$ 21.88
US$ 26.68